|Articles|November 1, 2019
- BioPharm International-11-01-2019
- Volume 32
- Issue 11
BioPharm International, November 2019 Issue (PDF)
Click the title above to open the BioPharm International November 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Biopharma modeling, now and five years from nowabout 6 years ago
A Diverse Landscape of Patent Issues Seen in the US, UK, and the EUabout 6 years ago
Modeling Comes of Age in Biopharmaover 6 years ago
Applying Lessons Learned from the Semiconductor Industryover 6 years ago
What’s New in Manufacturing: Downstream Technologiesover 6 years ago
KUBio Box for Viral Vectorsover 6 years ago
Zippered Lab Coatover 6 years ago
More Consistent Drug Inspection System on Horizonover 6 years ago
Signatures–What’s in a Name?Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FAQ: What You Need to Know About Agentic AI in Drug Discovery
2
Coya Raises $11.1 Million to Advance Immunomodulatory ALS Program
3
AstraZeneca’s $15 Billion Investment Deepens China R&D and Manufacturing Footprint
4
FDA Priority Review of Subcutaneous Lecanemab Signals Shift in Alzheimer’s Treatment Delivery
5
